Nicholas Ramos has extensive experience in the field of radiochemistry, currently serving as the Director of Radiochemistry at Radiopharm Theranostics since February 2023. Prior positions include Site Radiochemist at PharmaLogic Holdings Corp., Director of Radiochemistry and Manufacturing at NCM-USA, and Project Scientist/Radiochemist at Karmanos Cancer Institute. Key responsibilities in previous roles have involved the installation and maintenance of analytical equipment, development of radiochemistry protocols, supervision and training of staff, and quality control for radiopharmaceutical production. Nicholas holds a Bachelor's degree in Chemistry from the University of Mount Saint Vincent and has pursued further education in Medicinal Chemistry at the University at Buffalo.